Objectives: An aqueous extract and fraction from the marine sponge Petromica citrina have antibacterial activity. We performed a chemical and biological characterization of the antibiotic substance from P. citrina and investigated its mode of action on Staphylococcus aureus cells.
Introduction
The discovery of the first antibiotics in the first half of the 20th century left society and the scientific community unprepared for the emergence of antibiotic-resistant bacteria. This resistance has spread rapidly, and the infections caused by Staphylococcus aureus and other resistant strains of pathogenic bacteria, such as Enterococcus faecalis, Mycobacterium spp., Neisseria gonorrhoeae and Staphylococcus epidermidis, are currently a considerable problem. For example, even vancomycin, which was the last resource for the treatment of infections caused by methicillinresistant S. aureus (MRSA), has recently been rendered ineffective. 1, 2 Clearly, the emergence and clinical significance of drug-resistant bacterial infection have created an urgent need for the rapid and continued development of new classes of antibiotics that can keep pace with the changing face of bacterial antibiotic susceptibility. Thus, the discovery and development of new antibiotics has become a high priority in biomedical research. 3 Sponges are among the richest sources of pharmacologically active chemicals from marine organisms. They are known to produce many different compounds with antiviral, antifungal and antibacterial activities. 4 In a previous study to identify new 5 In another study, it was observed that the aqueous extract of P. citrina showed inhibitory activity against coagulasenegative staphylococci (CoNS) strains isolated from bovine mastitis. 6 Since this marine sponge showed the best spectra against antibiotic-resistant strains and very little data about this species have been published, it was selected for subsequent analysis. The purpose of this study was the chemical identification and biological characterization of the antibiotic substance from P. citrina sponge. The mechanism of action of this substance on staphylococcal cells was also investigated.
Materials and methods

Sponge sampling
Samples of P. citrina sponge were collected by scuba-diving at a depth of 4 -20 m at Cagarras Archipelago (23801 ′ S-43811 ′ W), located in Rio de Janeiro, south-eastern Brazil (south-western Atlantic).
Bacterial strains and culture conditions
The antibacterial activity of P. citrina was assayed against the type strains E. coli ATCC 25922, S. aureus ATCC 29213, S. epidermidis ATCC 12228, Mycobacterium fortuitum ATCC 6841, Mycobacterium smegmatis ATCC 14468, N. gonorrhoeae ATCC 49226 and Pseudomonas aeruginosa ATCC 27853. Antibacterial activity was also analysed against clinical bacteria previously characterized as follows: E. faecalis (resistant to chloramphenicol, erythromycin, kanamycin and vancomycin); 7 S. aureus (MRSA) and S. epidermidis (resistant to ampicillin, cefoxitin, ceftriaxone, ciprofloxacin, imipenem, kanamycin, methicillin and penicillin); 8 M. fortuitum and Mycobacterium massiliense (recently renamed as Mycobacterium abscessus subsp. bolletii) obtained from Brazilian epidemics of post-surgical infections; 9 and N. gonorrhoeae (resistant to ciprofloxacin) and N. gonorrhoeae (resistant to penicillin and tetracycline). 10 All bacteria were grown in brain heart infusion (BHI) medium at 378C for 18 h, except N. gonorrhoeae strains, which were grown in chocolate GC agar at 378C in an atmosphere with 3% -7% CO 2 for 48 h, and Mycobacterium spp. strains, which were grown for 7 days in Lowenstein-Jensen ('LJ') medium at 378C. All culture media used were provided by Difco (Detroit, MI, USA).
S. aureus ATCC 29213 was used in the bioassay-guided fractionation and biological characterization of the antibiotic substance isolated from P. citrina. Protoplasts of S. aureus were obtained from 5 mL of the cultures in early log growth, where the cells were treated with a sucrose solution (30% sucrose/0.05 M Tris, pH 7.5/0.145 M NaCl). After centrifugation at 17000 g for 5 min, the cells were treated with 50 mL of the sucrose solution, 50 mg/mL lysozyme (Sigma-Aldrich, St Louis, MO, USA) and 1 mg/mL lysostaphin (Sigma-Aldrich).
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Extraction and identification of the antibiotic substance
The bioactive fraction was obtained as described by Marinho et al. 5 Briefly, frozen sponge P. citrina (4.86 g) was lyophilized, crushed and extracted exhaustively using methanol as solvent at room temperature. The combined filtrate was concentrated in a vacuum to obtain a crude methanolic extract. The methanolic extract was re-suspended in methanol/water (9: 1) and sequentially partitioned into hexane (897.8 mg), chloroform (271.7 mg), ethyl acetate (255.1 mg) and aqueous residue (1.09 g) for subsequent bioassays. All organic solvents used were of analytical grade and were provided by Tedia Brazil (Rio de Janeiro, RJ, Brazil). Antibacterial activity of all fractions (4096 mg/L) was assayed against S. aureus ATCC 29213 and the bioassay-guided fractionation demonstrated that the aqueous residue was the most active one.
The bioactive fraction (aqueous residue) (1 g) was dissolved in distilled water (2 mL) and applied to a chromatography column packed with Sephadex LH-20 adsorbent and eluted with a system of solvents of decreasing polarity from water to methanol. Forty-four fractions, each of 25 mL, were collected and concentrated in vacuo. Fractions were analysed by bioautography to identify the growth-inhibitory substance of S. aureus. 12 The active fractions eluted from the column with 50% and 60% methanol (in water) were combined, concentrated (20.4 mg) and coded as PRM23. The antibiotic substance present in the PRM23 active fraction was identified by its 1 H-NMR, 13 C-NMR and mass spectra.
Assay for antibacterial activity
The antibacterial activities of the aqueous extract and fractions from bioassay-guided fractionation were determined against the growth of bacteria by the agar diffusion method as described in Marinho et al.
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Briefly, 20 mL of the fractions was spotted on BHI agar and 10 5 cells of S. aureus in 3 mL of BHI soft agar were poured over the plates. Plates were incubated at 378C for 18 h, 48 h (for Neisseria strains) or 7 days (for Mycobacterium strains), and the inhibition zones around the spotted extract or fractions were measured. Inhibition zones ≥8 mm were considered indicative of inhibitory activity.
Determination of MIC and MBC
The determination of MIC was performed in 96-well microplates by the microdilution method in Mueller-Hinton broth (Difco) medium, according to the CLSI. 13 S. aureus cells (10 4 cfu/mL) were inoculated in the broth with the active fraction (4096-2 mg/L) and incubated at 378C for 18 h. The MBC was determined after the MIC assays. In wells where MIC results showed no bacterial growth, an aliquot of 0.01 mL was seeded in Mueller-Hinton agar without addition of drugs and bacterial growth was evaluated for MBC determination. After 18 h at 378C, if the MIC¼MBC or if the MBC was one, two or three dilutions above the MIC, the activity was considered bactericidal. 14 
Mode of action on staphylococci cells
The active fraction (final concentration MIC value) from P. citrina was added to early log growth phase cells of S. aureus in 20 mL of BHI medium. A culture of S. aureus cells in early log growth phase in 20 mL of BHI medium without the antibacterial fraction or sterile BHI medium was added to controls. The cultures were then maintained at 378C and the optical density at 600 nm was determined at 1 h intervals for 4 h. To analyse a possible mode of action of the active fraction on S. aureus cells, 10 mL of each sample was collected for Gram staining and subsequent observation by light microscopy. The same procedures were performed with protoplasts of S. aureus.
For transmission electron microscopy, bacterial suspensions from the previous experiments were attached to carbon-coated grids (400 mesh; Ladd Research Industries Inc., Williston, VT, USA), washed three times with sterile water and negatively stained with 1% uranyl acetate. The grids were viewed on a Morgani electron microscope (FEI Co., Hillsboro, OR, USA) operated at 100 kV. 
Cytotoxicity bioassays
A microassay for cytotoxicity in the L929 (murine fibrosarcoma) cancer cell line was performed using the MTT method. 15 An adherent cancer cell line at a concentration of 0.3×10 6 cells/mL was seeded in 96-well microplates. The adherent cells were incubated for 24 h to allow cell attachment. The active fraction was added to the cell culture at concentrations of 200-3.1 mg/L, and the cells were incubated for 3 days. The MTT solution was added 3 h before the end of the incubation time. Cell survival was evaluated with a multiwell scanning spectrophotometer at 540 nm.
Results and discussion
The discovery of new antibiotics is important due to the increasing incidence of multiple resistance of pathogenic microorganisms to drugs that are currently in clinical use. 3 Moreover, many promising candidates for new pharmaceuticals have been discovered from marine sponges, including several sterol metabolites. Some authors believe that sponges may be the richest source of sterol diversity in the entire animal kingdom. 4 Recently, our group demonstrated for the first time that the sponge P. citrina is a potential source of new drugs for the treatment of infections caused by antibiotic-resistant bacteria. We observed that extracts and aqueous fractions of P. citrina showed a large spectrum of activity against Gram-positive cocci, and that Gram-negative bacilli were less susceptible. 5 In this study, the aqueous extract from P. citrina inhibited the type strains M. fortuitum, N. gonorrhoeae, S. aureus and S. epidermidis. It also inhibited six clinical bacteria, including M. fortuitum, MRSA, methicillin-resistant S. epidermidis (MRSE), N. gonorrhoeae and VRE strains. Methicillin-resistant staphylococci infections mainly caused by S. aureus and by CoNS isolates have increased over the last two decades.
1 These antibiotic-resistant strains are the most frequently isolated pathogens from nosocomial bacteraemias, with attributable mortality rate ranging from 13% for CoNS to 42% for MRSA. In these cases, therapy is generally limited to the use of vancomycin and teicoplanin. However, the susceptibility of MRSA to vancomycin has been shown to be reduced, increasing the need for the development of alternative post-vancomycin antibiotics and other chemotherapeutic agents. 16 Interestingly, this is the first study that showed P. citrina extracts inhibiting M. fortuitum, a rapidly growing mycobacterium (RGM). This bacterium is an opportunistic microorganism and has been described in different outbreaks of RGM post-surgical infections and, more recently, after ophthalmic procedures and mammary implant surgery worldwide. 17, 18 Moreover, this extract presented potent action against N. gonorrhoeae strains, including two antibiotic-resistant strains. These strains were recently isolated and characterized in Brazil. 10 N. gonorrhoeae is the aetiological agent of gonorrhoea, one of the most commonly reported sexually transmitted diseases worldwide. The emergence of resistance to antimicrobial agents in gonococci has complicated its treatment and control. 19 For the isolation of the antibacterial substance from P. citrina, the aqueous extract was fractionated with bioassay guidance and the main active compound, a sulphated sterol, was identified. The structure of compound 1 (Figure 1 ) was identified as halistanol trisulphate (241,25-dimethylcholestane-2b,3a,6a-triol trisodium sulphate) based on detailed NMR and mass spectra analysis. The molecular ion of 1 [M-Na] 2 was detected using negative high-resolution fast atom bombardment mass spectrometry ('FABMS') (observed m/z 731.2195 and calculated m/z 731.2182 for C 29 H 49 O 12 S 3 Na 2 ). Therefore, halistanol trisulphate was quickly recognized by its spectroscopic properties and proton and carbon NMR data analysis, which were consistent with those previously reported. 20, 21 Steroid sulphates are often encountered in marine sponges of the orders Halichondrida and Haplosclerida, 22 including another species of Petromica, Petromica ciocalyptoides. 23 Sulphated compounds are known to have several biological activities, such as haemolytic and ichthyotoxic activities. 20 Previous reports from our group showed that the MIC of the aqueous extract of P. citrina for Staphylococcus spp. was 1024 mg/L. 5, 6 Therefore, we further tested the antibiotic substance present in P. citrina, halistanol trisulphate, against S. aureus ATCC 29213; the MIC observed was 512 mg/L and the MBC was ≥512 mg/L. Since the MBC and MIC values were the same, our results indicate a bactericidal activity of halistanol trisulphate. The cytotoxic activity of this substance was analysed in the L929 cancer cell line and it showed a CC 50 of 115.84 mg/L (where CC 50 stands for 50% cytotoxic concentration, defined as the concentration required to reduce the cell number by 50% compared with that for the untreated controls). Recently, similar studies with the aqueous extract of P. citrina also exhibited moderate toxicity against HEp-2 and Vero cell lines. 6 These results suggest that halistanol trisulphate exhibits potential antitumour activity.
Assays were conducted to examine the effect of halistanol trisulphate from P. citrina upon the growth of S. aureus. Addition of halistanol trisulphate at the MIC (512 mg/L) to log-phase cultures resulted in a 90% decrease in absorbance compared with the control sample (without halistanol trisulphate). The chemical characterization data of halistanol trisulphate have already been extensively explored, 20, 22, 24 but very little is known about its mechanism of action. Indeed, very few studies have shown the mode of action of antibacterial substances isolated from sponges. Marinho et al. 5 showed that the bioactive fraction from P. citrina affects protein biosynthesis in Staphylococcus spp. Therefore, inhibited protein biosynthesis could be a secondary effect. Thus, to investigate a possible mechanism of action of halistanol trisulphate from P. citrina, samples of early log growth phase cells of S. aureus were analysed by light microscopy. Under these conditions, the culture produced chains of Antibacterial activity of halistanol trisulphate 2399 JAC cells and some of them were undergoing binary division. We observed that the morphology of both S. aureus cells (Figure 2b ) and protoplasts ( Figure 2d ) changed after the first hour of the culture in the presence of halistanol trisulphate. The treatment plates showed drastic cell lysis, while in the controls (Figure 2a and c) , without halistanol trisulphate, the cells were intact after up to 4 h of culture. A better view of cell lysis in the presence of halistanol trisulphate could be observed under the electron microscope ( Figure 3) . We observed that halistanol trisulphate also caused lysis of S. aureus cells and of red blood cells (data not shown). These data suggest that halistanol trisulphate disrupts the cell membranes of both prokaryotic and eukaryotic cells. This antibacterial substance could have a direct mode of action on the membrane or it could cause the efflux of small molecules (e.g. potassium and amino acids) and dissipation of the membrane potential, resulting in the arrest of all cellular biosynthesis. Sterols such as halistanol trisulphate are also of interest as a means of understanding the function of biological membranes. Surface-active agents from marine environments have tremendous potential to be used in industrial processes, for environmental remediation and as drugs. 25 In conclusion, we demonstrated for the first time the antimicrobial and cytotoxic activities of halistanol trisulphate isolated from the sponge P. citrina. This substance exhibited antibacterial activity against strains of medical importance. In S. aureus cells this substance exhibited significant activity by breaking the cell membrane. Our results indicate that halistanol trisulphate is a new candidate for research on antibacterial substances (antibiotics or disinfectants) for the control of infections caused by antibiotic-resistant bacteria.
